The General Pharmaceutical Council (Amendment) Rules Order of Council 2022

Type Statutory-Instrument
Publication 2022-06-21
State In force
Department King's Printer of Acts of Parliament
PDF Download
articles Not indexed
Reform history JSON API

Made: 21st June 2022

Laid before Parliament: 23rd June 2022

Laid before the Scottish Parliament: 23rd June 2022

Coming into force: 6th October 2022

At the Council Chamber, Whitehall on the 21st day of June 2022By the Lords of Her Majesty’s Most Honourable Privy Council

In accordance with article 66(4) of that Order, the Rules shall not come into force until approved by Order of the Privy Council.

Citation and commencement

1

This Order may be cited as the General Pharmaceutical Council (Amendment) Rules Order of Council 2022 and comes into force on 6th October 2022.

Privy Council Approval

2

Their Lordships, having taken the Rules as set out in the Schedule to this Order into consideration, are pleased to, and do, approve them.

SCHEDULE — The General Pharmaceutical Council (Amendment) Rules 2022

The General Pharmaceutical Council makes these Rules in exercise of the powers conferred by articles 61(1), (2)(a) and (6)(b) and 66(1) of the Pharmacy Order 2010[^f00002].

In accordance with article 66(3) of that Order the Pharmaceutical General Council has consulted such persons or organisations as it considered appropriate.

Citation and commencement

1

These Rules may be cited as the General Pharmaceutical Council (Amendment) Rules 2022 and come into force on 6th October 2022.

Amendment of the General Pharmaceutical Council (Appeals Committee Rules) Order of Council 2010

2

  • attend” means— to be physically present at a meeting or hearing, or, to be present at a meeting or hearing by teleconference or video link;

; and

  • present” includes being in a meeting or hearing by teleconference or video link and “presence” is to be construed accordingly;

(2A) At the discretion of the chair, meetings or hearings of the Committee arranged under these Rules may be conducted by teleconference or video link.

(a) state— (i) the date, time and venue of the hearing, or (ii) when the hearing is to be conducted by teleconference or video link, the date and time of the hearing and instructions on how to access the hearing;

(5) Reference to a hearing under this rule includes hearings conducted by teleconference or video link.

Amendment to the General Pharmaceutical Council (Fitness to Practise and Disqualification etc Rules) Order of Council 2010

3

  • attend” means— to be physically present at a meeting or hearing, or, to be present at a meeting or hearing by teleconference or video link;

; and

  • present” includes being present at a meeting or hearing by teleconference or video link, except in the phrase “present their case”, and “presence” is to be construed accordingly;

and

(2A) At the discretion of the chair, meetings and hearings of the Committee arranged under these rules may be conducted by teleconference or video link.

(a) state— (i) the date, time and venue of the hearing, or (ii) when the hearing is to be conducted by teleconference or video link the date and time of the hearing and instructions on how to access the hearing;

(a) state— (i) the date, time and venue of the hearing, or (ii) when the hearing is to be conducted by teleconference or video link, the date and time of the hearing and instructions on how to access the hearing;

(5) Reference to a hearing under this rule includes hearings conducted by teleconference or video link.

Signed

Richard Tilbrook — Clerk of the Privy Council

Explanatory note

(This note is not part of the Order)

EXPLANATORY NOTE

This Order amends the General Pharmaceutical (Appeals Committee) Rules 2010 (the ‘Appeals Committee Rules’) and the General Pharmaceutical Council (Fitness to Practise and Disqualification etc.) Rules 2010 (the ‘Fitness to Practise Rules’).

Paragraph 2 of the Schedule amends the Appeals Committee Rules and paragraph 3 of the Schedule amends the Fitness to Practise Rules by:

A full impact assessment of the effect that this instrument will have on costs of business, the voluntary sector and the public sector is available from https://www.pharmacyregulation.org/sites/default/files/document/gphc-remote-hearings-consultation-equality-impact-analysis-may-2022.pdf

Footnotes

[^f00001]: S.I. 2010/231, to which there are amendments not relevant to this Order.

[^f00002]: S.I. 2010/231, to which there are amendments not relevant to this Order.

[^f00003]: Rules as contained in the Schedule to the General Pharmaceutical Council (Appeals Committee Rules) Order of Council 2010 (S.I. 2010/1614).

[^f00004]: Rules as contained in the Schedule to the General Pharmaceutical Council (Fitness to Practise and Disqualification etc Rules) Order of Council 2010 (S.I. 2010/1615).

Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.

This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence. legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.